本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lyra Therapeutics

0.0865
-0.0055-5.98%
盤後0.08900.0025+2.89%19:37 EDT
成交量:122.66萬
成交額:10.95萬
市值:569.86萬
市盈率:-0.06
高:0.0952
開:0.0950
低:0.0850
收:0.0920
資料載入中...
2025/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/13

重要事件披露

Form 8-K - Current report
2025/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/16

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/08/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/15

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/06/19

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/21

重要事件披露

Form 8-K - Current report